By Brenda Goodman, CNN (CNN) — Overweight and obese adults who took the injected medication Mounjaro lost more weight and were more likely to meet specific weight loss targets than people on a similar competitor, Ozempic, according to a new study of people taking the drugs in the real world. Both Ozempic, or semaglutide, and Mounjaro, or terzepatide, mimic the effects of the gut hormone GLP-1, which stimulates the body’s production of insulin and slows the passage of food through the stomach. GLP-1 also signals the brain to help control appetite. Terzepatide also stimulates a second gut hormone, called GIP, which may help boost its effects. The drugs are prescribed to treat type 2 dia
Hence then, the article about users of diabetes drug mounjaro lost more weight than those on ozempic large study finds was published today ( ) and is available onNews channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Users of diabetes drug Mounjaro lost more weight than those on Ozempic, large study finds )